An Update on Retinopathy of Prematurity (ROP)

Area of Science:

• Ophthalmology
• Neonatology
• Vascular Biology

Background:

• Retinopathy of prematurity (ROP) is a significant cause of blindness in premature infants.
• The disease's severity ranges from self-resolving cases to severe retinal detachment and blindness.
• Increasing preterm birth rates and suboptimal neonatal care contribute to rising ROP-related blindness.

Purpose of the Study:

• To highlight the spectrum of retinopathy of prematurity (ROP).
• To emphasize the factors contributing to increased ROP blindness.
• To outline strategies for ROP prevention and management.

Main Methods:

• Review of clinical spectrum and contributing factors of ROP.
• Analysis of treatment modalities including laser photocoagulation, anti-VEGF therapy, and surgery.
• Discussion of preventative measures and collaborative care approaches.

Main Results:

• ROP presents a wide clinical spectrum, with some forms treatable by medical or surgical intervention.
• Suboptimal neonatal care and delayed diagnosis exacerbate ROP and lead to blindness.
• Atypical ROP forms are emerging in heavier infants in developing nations.

Conclusions:

• Effective prevention of ROP blindness requires stringent protocols for oxygen use and sepsis management.
• Timely screening and collaborative efforts between neonatologists and ophthalmologists are essential.
• Multifaceted strategies are needed to combat the increasing incidence of ROP-related vision impairment.